Stat5b inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the signal transducer and activator of transcription 5b (Stat5b) protein. Stat5b is a crucial component of intracellular signaling pathways that play a pivotal role in cellular growth, differentiation, and immune response. These inhibitors are meticulously crafted molecules that interfere with the interaction between Stat5b and its downstream signaling partners, thereby impeding the transmission of signals that drive cellular processes. The design of Stat5b inhibitors involves a deep understanding of the protein's structural and functional attributes, allowing researchers to develop compounds that bind to specific regions of the protein's active sites, thereby blocking its enzymatic activity.
The development of Stat5b inhibitors entails rigorous molecular modeling and structure-activity relationship studies to refine the compounds' chemical structures for optimal binding affinity and selectivity. Researchers often employ computational methods, such as docking simulations and molecular dynamics simulations, to predict the interactions between the inhibitors and the target protein. This iterative process guides the modification of chemical moieties within the inhibitor's structure to enhance its potency and specificity. By inhibiting the activity of Stat5b, these compounds can offer insights into the underlying cellular pathways and mechanisms that influence cellular fate and function. The exploration of Stat5b inhibitors contributes to advancing our understanding of intracellular signaling processes and may open doors to novel avenues of research in various scientific disciplines.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pimozide | 2062-78-4 | sc-203662 | 100 mg | $104.00 | 3 | |
Blocks STAT5B activation by inhibiting JAK2-mediated phosphorylation. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Non-peptidic small molecule that inhibits STAT5B dimerization and nuclear translocation. | ||||||
Stat5 Inhibitor | 285986-31-4 | sc-355979 sc-355979A | 10 mg 100 mg | $208.00 $1532.00 | 36 | |
Disrupts STAT5B DNA binding and transcriptional activity by targeting the SH2 domain. | ||||||
Nifuroxazide | 965-52-6 | sc-204128 sc-204128A | 500 mg 5 g | $203.00 $520.00 | 5 | |
Inhibits STAT5B phosphorylation and nuclear translocation, suppressing its activity. | ||||||
Pyrimethamine | 58-14-0 | sc-208190 sc-208190A sc-208190B | 1 g 5 g 25 g | $80.00 $238.00 $825.00 | 5 | |
Disrupts STAT5B signaling by inhibiting its phosphorylation and DNA binding. | ||||||
Stat3 Inhibitor VI, S3I-201 | 501919-59-1 | sc-204304 | 10 mg | $151.00 | 104 | |
Inhibits STAT5B activation and nuclear translocation through JAK2 inhibition. | ||||||